Journal of Medicinal Chemistry · 2010 · 29 citations · 14 references
Life SciencesMedicinal ChemistryPharmacologyAntimicrobial ResistanceDrug DiscoveryMycologyAntifungal AgentsAntifungal PharmacologyAntifungal ResistanceAntifungal TherapyFungal BiochemistryFungal PathogenesisAntifungal Drug ResistanceAspartic ProteasesCandidiasis Drug ResistanceFungal Drug DiscoveryFungal Drug ResistanceFungal Enzyme InhibitorsNovel Antifungal Drug DevelopmentVaginal Candidiasis
The screening of a library of small molecule peptidomimetics toward secreted aspartic proteinase-2 (SAP2) of Candida albicans allowed us to identify two compounds that showed in vitro inhibitory potency comparable to pepstatin A. In an experimental model of vaginal candidiasis, the two candidate compounds were as active as a therapeutic dose of fluconazole. Importantly, this activity was fully preserved when the challenger was a fluconazole-resistant strain of the fungus. Altogether, our data demonstrate SAP2 as a valid C. albicans target for the development of new drugs against this important human pathogen.
14
Martin Schaller, Matthias Bein, Hans Christian Körting et al. · Infection and Immunity · 2003 · 178 citations · Full text
Flavia De Bernardis, Silvia Arancia, Luisella Morelli et al. · The Journal of Infectious Diseases · 1999 · 169 citations · Full text